Stuarttherapeutics
12 employees on LinkedIn · 1 known investors
Stuart Therapeutics is a clinical-stage pharmaceutical company developing synthetic collagen mimetic peptides (its PolyCol platform) designed to bind and repair damaged helical collagen in the extracellular matrix. Its therapies target chronic eye diseases including dry eye disease, glaucoma, and inherited retinal disorders such as retinitis pigmentosa and age-related macular degeneration.
Founders & leadership
RO
Robert O. BarattaCo-founder
SD
Shawn DeLoreyinOperations & Corporate Development (inventor of PolyCol)
Investors · 1
Frequently asked questions
- What does Stuarttherapeutics do?
- Stuart Therapeutics is a clinical-stage pharmaceutical company developing synthetic collagen mimetic peptides (its PolyCol platform) designed to bind and repair damaged helical collagen in the extracellular matrix. Its therapies target chronic eye diseases including dry eye disease, glaucoma, and inherited retinal disorders such as retinitis pigmentosa and age-related macular degeneration.
- Who founded Stuarttherapeutics?
- Stuarttherapeutics was founded by Robert O. Baratta.
- Who are Stuarttherapeutics's investors?
- Stuarttherapeutics's investors include BioBrit.